The a-melanocyte-stimulating hormone (a-MSH) receptor of B16 mouse melanoma cells was characterized by photoaffinity labelling using radiolabelled photoactive derivatives of a-MSH. A doublet band of 43-46 kDa representing a ligand-receptor complex was identified. A novel adaptation of the streptavidin/biotin-based affinity system was used to isolate the a-MSH receptor. A probe was synthesized which contained biotin connected to a photolabelled a-MSH analogue via a cleavable disulphide linker and which displayed high affinity for the a-MSH receptor. Streptavidin-coated magnetic beads were used as a solid support instead of an affinity column. Covalently linked probe-receptor complexes solubilized in Triton X-100 were equilibrated with the beads, and after magnetic separation and washing, specifically bound complexes were treated with dithiothreitol to cleave the disulphide bridge in the biotin-peptide spacer arm and so release the receptor-ligand complex. The identity of the isolated protein was established by SDS/PAGE analysis. Methods to achieve purification to homogeneity and to allow quantitative isolation of the receptor are discussed.
INTRODUCTION
a-Melanocyte stimulating hormone (a-MSH; Ac-Ser-TyrSer-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) is a 13-amino-acid-peptide produced in the pituitary by posttranslational cleavage of pro-opiomelanocortin. It is known to be a potent stimulator of pigment dispersion in lower vertebrates and to induce melanogenesis in various mammalian cells. It is also recognized as having a role as a neuropeptide, exhibiting a wide range of behavioural and electrophysiological effects in mammals. The mechanism of action of a-MSH is thought to be receptor-mediated. It binds to the cell surface of cultured melanoma cells, raising the intracellular concentration of cyclic AMP. This in turn produces an increase in tyrosinase activity, leading to an increase in melanin content (Eberle, 1988) .
Structure-activity relationships for a number of analogues and conjugates of a-MSH have been established (Eberle, 1988) . The analogue [Nle4,D-Phe7]a-MSH, first described by Sawyer et al. (1980) has been shown to have binding affinity and biological activity of the order of 10 x that of a-MSH (Eberle, 1988) , and is routinely used in our laboratory for investigations into the binding efficiency of various analogues and derivatives of the native hormone. Structure-activity relationships have established that alterations to the N-terminus of the peptide do not abolish activity (Eberle, 1988) . The relative ease of chemical substitution to the N-terminus makes it an ideal site for the attachment of non-amino acid groups such as biotin. Na-Biotin[Nle4,D-Phe7]ac-MSH was first prepared by Chaturvedi et al. (1984) and was shown to retain a high specificity for the receptor.
The technique of photoaffinity labelling has become an important tool for the identification and characterization of hormone receptor proteins (Hazum, 1983; Eberle, 1989) . The photoaffinity label we chose for this study was 4-(1-azi-2,2,2-trifluoroethyl)benzoic acid (ATB), a diazirine derivative first introduced by Nassal (1983) . Previously, the existence of a-MSH receptors on various mouse and human cell lines has been demonstrated by photoaffinity labelling using radiolabelled photoactive peptide analogues (Scimonelli & Eberle, 1987; Solca et al., 1989) . Full characterization of the interaction of the peptide with its receptor, however, will only be possible if the receptor proteins can be isolated and purified. This has yet to be achieved for the receptor to a-MSH.
In this paper, we describe the development of a new technique for the isolation and purification of z-MSH receptors from cultured melanoma cells. The two main features of the method are as follows: (a) The application of the streptavidin/biotin affinity system using a functionally unimpaired cleavable biotinyl derivative of a-MSH as the affinity ligand. (b) The use of magnetizable beads as a solid support instead of the classical affinity chromatography column. These beads are non-porous, uniform, supermagnetic polystyrene particles. Originally developed for immunoassays, the use of magnetic beads in combination with the biotin/streptavidin system has more recently found wider application in molecular biology (Uhlan, 1989) .
Until now, attempts to purify hormone receptors have been greatly hindered on the one hand by their paucity, and on the other by the relatively low yield obtained using classical affinity chromatography. The method we have developed for the isolation of the a-MSH receptor is powerful and highly reproducible. It could also be easily scaled up to provide sufficient material for' sequence determination. The isolation method is presented diagrammatically in Fig. 1 All the peptides used in this study were prepared by solidphase synthesis using the Fmoc strategy as developed by Atherton & Sheppard (1989 in binding buffer (50 mM-Tris/HCI, pH 7.4, 1 mM-CaCl2, 10 mM-MgCI2, 100 mM-NaCl, 5 mm-KCI and 0.3 mM-1,10-phenanthroline) in the presence or absence of a 1000-fold excess (1,tM) of unlabelled [Nle4,D-Phe7]a-MSH. After 2 h incubation at 22°C in the dark, the upper surface of the flask was peeled off and the cells were irradiated on ice with u.v. light of 320 nm (2 x 15 W fluorescent tubes; FL15E UV-320) at a distance of about 10 cm. After irradiation, the cells were washed and then scraped from the flask, resuspended in 10 mM-Tris/HCI, pH 7.4, and washed by low-speed centrifugation (700 g) three times to remove further unbound ligand. The cells were then resuspended in homogenization buffer [10 mM-Tris/HCl, pH 7.4, 0.3 mM-phenanthroline, 1 mM-phenylmethanesulphonyl fluoride (PMSF)]. They were kept on ice for 30 min and then homogenized by five passages through a 21-gauge needle and five passages through a 25-gauge needle. The homogenate was then centrifuged at 20000 g for 30 min and the pellet (crude membrane fraction) was resuspended in solubilization buffer (10 mM-Tris/HCI, pH 7.4, 1.5 % Triton X-100, 1 mM-PMSF, 1 mM-EDTA and 1 ,ug of leupeptin/ml) (0.5 ml/100 mg wet weight). This suspension was kept on ice for 60 min and then centrifuged at 100000 g for 60 min to remove non-solubilized material. N-Ethylmaleimide (NEM) was included in the buffers at 0.5 mm to protect the disulphide bridge when NO-Biotin-SS-[Nle4,D-Phe7,ATB-Lys"1]a-MSH was used as the ligand.
Magnetic streptavidin affinity purification of a-MSH receptor complexes Prewashed Dynabeads M-280 (100,cl; 100 mg/ml) streptavidin (Dynal, New Ferry, Merseyside) was added to 500,u1 of Triton X-I00-solubilized biotinylated probe-receptor covalent complexes in a 1.5 ml Eppendorf tube. The mixture was incubated with gentle mixing at 4°C for 30 min. The tube was then placed in a strong magnetic field (Magnetic Particle Concentrator; Dynal) for a few minutes. During this time the magnetic beads with bound biotinylated complexes were attracted to the wall of the tube by the magnetic field, forming a firm pellet. The supernatant containing the unbound material was removed using a pipette while the magnet remained in place. The beads were then released from the magnet and subjected to several cycles of washing using the following buffers: 10 mM-Tris/HCL, pH 7.4, 0.5 % Triton X-100, 5 mM-EDTA and 1 mM-PMSF (buffer A); buffer A + 0.1 % SDS; buffer A + 1 M-NaCl. Magnetic separation was performed between each washing. Elution of the complexes was achieved by gentle agitation of the beads in a 10 mmTris/HCl, pH 7.4, buffer containing 50 mM-dithiothreitol (DTT) and 1 % SDS at 30°C for 15 min. The supernatant was removed by magnetic separation of the beads and concentrated in Filtron MicroseplO microconcentrators.
SDS/polyacrylamide-gel electrophoresis SDS/PAGE was performed using the discontinuous buffer system of Laemmli (1970) , with homogeneous 0.75 mm thick slab gels containing 10 % acrylamide monomer in the separating gel and 4% acrylamide in the stacking gel. Sample buffer was 
RESULTS

Photoaffinity labelling
The strategy we have developed requires the covalent labelling of the receptor prior to solubilization and magnetic separation. activity remaining at the origin of the gels, suggesting aggregation of the proteins. As an alternative procedure, samples were incubated at 37°C for 30 min prior to loading on the gel.
Photoaffinity labelling with iodinated N2-Biotin-SS-[Nle4,DPhe7,ATB-Lys"c]a-MSH showed identical results, i.e. a major specific doublet corresponding to molecular mass of 43-46 kDa (Fig. 3) . In other control experiments, in which the probe was u.v.-irradiated prior to incubation, no bands were apparent on the gel, indicating the specificity of the labelling (Fig. 3, lane 6) . The presence or absence of the reducing agent ,J-mercaptoethanol did not change the electrophoretic mobility of the complex, suggesting that the labelled protein is unlikely to be a disulphidelinked oligomer (Fig. 3, lanes 2 and 3) . Experiments carried out using the probe Na-Biotin-[Nle4D-Phe7,ATB-Lys11]a-MSH gave identical results. At the concentration of labelled ligand used, the non-specific activity was estimated to be less than 10 %. The membranes were exposed to u.v. light and harvested as described above. The crude membrane fraction contained more than half of the initial radioactivity (1.2 x 106 c.p.m.; 60%). After solubilization, approx. half of the remaining activity was associated with the solubilized membrane preparation (6.8 x l05 c.p.m.; 34% of total). The loss at this stage is most probably associated with the incomplete solubilization of the membranes by Triton X-100, and possibly the presence of some receptor-ligand complexes in organelles as a result of internalization during the initial 2 h incubation period.
An estimation of the covalent receptor-ligand complexes present in the solubilized membrane fraction was obtained by SDS/PAGE analysis of an aliquot containing 104 c.p.m. The band taken to represent the receptor-ligand complex (43-46 kDa) contained 8 x 102 c.p.m. From this analysis, it is estimated that the covalent receptor-ligand complex in the solubilized membrane fraction represents approx. 3 % of the radioactivity initially bound to the cells (5.4 x 104 c.p.m.; 2.7 %). An estimate of the efficiency of photoaffinity labelling may be made by using the data above obtained from SDS/PAGE analysis of the solubilized membrane. If it is assumed that all the radioactivity associated with the solubilized membrane is receptor-ligand complex, and that denaturation during SDS/PAGE releases uncovalently bound ligand, then the ratio 8 x 102/104 gives the proportion of covalent receptor-ligand complex (8 %). This is the worst-case estimate, as some of the radioactivity in the solubilized membrane fraction will be due to the small proportion of non-specifically bound ligand and, in addition, some of the covalent receptorligand complex in the SDS/PAGE analysis may be seen at the top of the gel as receptor aggregates.
In a separate experiment to estimate the efficiency of the binding of the receptor-ligand complexes to the steptavidin beads, an aliquot of solubilized membrane fraction containing approx. 106 c.p.m. was incubated with the beads as described, and after magnetic separation 5 x 105 c.p.m. (50 %) was found associated with the beads. Subsequent incubation of the solubilized membrane fraction with a second sample of beads resulted in no detectable radioactivity associated with the beads. This suggests that, within detectable limits, 100 % of the biotinylated receptor-ligand complexes are separated on to the beads. The most likely cause of the 50 % of radioactivity not separated on to the beads is cleavage of the biotin from the ligand by reduction ofthe disulphide bridge due to incomplete protection, particularly during the initial incubation in the presence of the cells. In this context, it is worthy of note that a more stable but eventually cleavable link to replace the disulphide bridge would significantly increase yields. The specificity of the binding to the beads was tested by a parallel experiment using an aliquot incubated in the presence of excess biotin, which completely inhibits binding of radioactivity to the beads.
Following extensive washing of the beads with buffers to remove non-specifically adsorbed probes, the receptors-ligand complexes were eluted from the beads with 10 mM-Tris/HCl, pH 7.4, containing 50 mM-DTT and 1 % SDS. After elution, less than 10 % of the radioactivity (7 x 104 (Fig. 4b) . was identical to the one obtained from the non-purified sample, showing a major doublet band corresponding to molecular mass of 43-46 kDa and a minor band of 57 kDa representing the nonspecific labelling. In the corresponding photograph of the gel stained with Coomassie Blue (Fig. 4a) , it can be seen that after elution from the beads the concentration of non-specifically bound proteins has been decreased to below that detectable by this staining procedure (Fig. 4a, lanes 6 and 7) .
DISCUSSION
In this report we have described a novel approach to the isolation and purification of the a-MSH receptor involving Solca et al. (1991) , who tested various B16 murine melanoma subclones and reported the identification of three different subtypes of the a-MSH receptor, which they suggested represent very similar proteins.
The main objective of this investigation was to develop a method for the isolation of the a-MSH receptor, a prerequisite for the elucidation of its structure and function. To our knowledge, there has been no published report on this objective to date. The extreme paucity of the receptor, particularly in cultured cells, dictates that a highly efficient isolation method be employed. The application of (strept)avidin/biotin technology in receptor isolation was first proposed by Hoffmann & Kiso (1976) . It was prompted by the exceptional affinity (Ka = 101' M-1) of the biotin/avidin binding. More recently, Hoffmann et al. (1988) described a method for the isolation of a corticotropin-binding protein from adrenal particulates using a desthiobiotinyl derivative as a probe and affinity chromatography on a succinoylavidin-Sepharose column. Streptavidin, which has an equal affinity for biotin, is considered to be superior to avidin because it shows relatively low non-specific binding.
There are several strategies for the use of streptavidin/biotin systems. In our first attempt to isolate the ac-MSH receptor, we used the probe Na-Biotin-[Nle4,D-Phe7]a_MSH as an affinity ligand. This ligand was found to retain its high affinity to the receptor and the ability to interact with streptavidin. Using this probe, B16 cells were cross-linked by u.v. irradiation and the solubilized probe-receptor complexes were incubated with the beads. After binding of the biotinylated complexes the beads were washed with buffer to remove non-specifically bound proteins. Attempts were made to dislodge the receptor complexes from the beads using excess biotin, 6M-guanidinium chloride 
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and 70 % formamide. The recovery in all cases was poor. This led us to the development of the NO-Biotin-SS-[Nle4,D-Phe7,ATBLys11]a-MSH probe, having a cleavable disulphide bridge in the spacer unit between the biotin and the peptidyl ligand. Although the synthesis gave low yields of the target ligand, sufficient material was obtained to provide receptor complexes using different experimental conditions. NEM was included in the purification steps to minimize disulphide bridge cleavage due to the presence of endogenous thiol groups. Elution of the receptor complexes was achieved by disrupting the disulphide linkage in the biotin ligand chain using DTT. The efficiency of this step in the recovery of receptor complexes was in excess of 90 %, with little contamination by released streptavidin. SDS/PAGE and autoradiographic analysis of the purified receptor complex revealed that it contains a major 43-46 kDa doublet band which was identical to that obtained for the crude solubilized membrane preparation.
